Researchers pinpoint why lymphoma patients may become resistant to specific therapy
With more targeted therapies being approved each year for cancer, the development of drug resistance…
Browsing: Lymphoma
New drug effective in overcoming ibrutinib resistance in mantle cell lymphoma
A study at The University of Texas MD Anderson Cancer Center demonstrated how a small…
Radiotherapy after chemotherapy may improve survival for patients with advanced Hodgkin’s lymphoma
Patients with advanced Hodgkin’s lymphoma who have large tumours at the time of diagnosis may…
Vaccination against Epstein-Barr virus might reduce the risk of developing Hodgkin’s lymphoma, study suggests
Cells of certain blood cancers such as Hodgkin’s lymphoma carry the protein CD30 on their…
AACR 2019: Single agent umbralisib effective for relapsed slow-growing lymphoma
A study at The University of Texas MD Anderson Cancer Center revealed the investigational drug…
Treatment guidelines for breast implant-associated lymphoma (BIA-ALCL)
The use of textured breast implants during augmentation or reconstructive surgery can slightly increase a…
Exposure to chemical in Roundup increases risk for cancer: study
Exposure to glyphosate—the world’s most widely used, broad-spectrum herbicide and the primary ingredient in the…
Scientists learn how common virus reactivates after transplantation
A new study in Science challenges long-held theories of why a common virus—cytomegalovirus, or CMV—can reactivate and…
Survivors of childhood Hodgkin lymphoma face high long-term risk of solid cancers
New research refines existing evidence that survivors of childhood Hodgkin lymphoma face an elevated risk…
ASH 2018: More than half of patients alive two years after receiving CAR-T therapy for diffuse large B-cell lymphoma in ZUMA-1 trial
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large…